Highlights from JLCS24 by Hidehito Horinouchi
The 65th Annual Meeting of the Japanese Lung Cancer Society was held at PACIFICO Yokohama from October 31st- November 2nd 2024.
It brought together leading experts in the field to address the urgent challenges of lung cancer treatment and research.
Under the theme “Combining Our Strengths to Conquer Lung Cancer,” the conference fostered collaboration and dialogue among clinicians, researchers, and advocates.
President Yuichiro Ohe, M.D., Ph.D., Chief of the Department of Thoracic Oncology and Deputy Director of the National Cancer Center Hospital, led discussions on innovative therapies, early detection strategies, and the importance of multidisciplinary approaches.
The event served as a vital platform for sharing groundbreaking research and enhancing collective efforts to improve patient outcomes in lung cancer care.
Hidehito Horinouchi is the Assistant Chief of the National Cancer Center Hospital. He also serves as the Secretary General of the Lung Cancer Study Group, Japan Clinical Oncology Group, and the Deputy Chief of the Center for Education and Professional Career Development at the National Cancer Center Hospital. He specializes in multimodal treatment strategies, including medical, surgical, and radiation oncology, for patients with thoracic malignancies.
Diversity and Inclusion in Thoracic Oncology
Diversity and Inclusion in Thoracic Oncology Cecilia Pompili, IASLC, DEI task force JLCS OFFICIAL Diversity Committee IASLC Global Member Survey on INCLUSIVITY.
Early-Stage NSCLC Korea Perspective
IASLC, JLCS OFFICIAL
Joint Symposium
Diagnosis and Treatment of Early-Stage NSCLC Korea Perspective Dr. Seong Yong Park.
Early-Stage NSCLC EU Belgium Perspective
IASLC, JLCS OFFICIAL Joint Symposium Diagnosis and Treatment of Early-Stage NSCLC EU Belgium Perspective Dr. Paul Van Schil IASLC President.
Early-Stage NSCLC Japan Perspective
IASLC, JLCS OFFICIAL Joint Symposium Diagnosis and Treatment of Early-Stage NSCLC Japan Perspective Hidehito Horinouchi.
IASLC, JLCS OFFICIAL Joint Symposium Diagnosis and Treatment of Early-Stage NSCLC
Chairs: Karen Kelly, Prof. Norihiko Ikeda, Dr. Paul Van Schil, Dr. Caicun Zhou, Dr. Seong Yong Park, Hidehito Horinouchi.
IASLC and JLCS Official Business Meeting
IASLC, JLCS OFFICIAL Business Meeting IASLC, Karen Kelly, Dr. Paul Van Schil, Heather Wakelee, JLCS OFFICIAL, Prof. Norihiko Ikeda, Prof. Nobuyuki Yamamoto, Tetsuya Mitsudomi, Dr. Isamu Okamoto, Dr. Makoto Nishio,Hidehito Horinouchi.
Proud to Mentor Japan’s Rising Star
Proud to Mentoring Japan’s Rising Star Masahiro Torasawa Distinguished Award for Young Investigator
Reconsidering the Cutoff Value for Sensitive and Refractory Relapses in Extensive-Stage SCLC in the Era of Immunotherapy.
“Meet the Experts From Korea Global Researcher Keunchil Park
Chair: Hidehito Horinouchi park’s Motto.”
More posts featuring Hidehito Horinouchi.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023